Tamara Ouspenskaia
Associate Director, Therapeutics Immunology & Protein Engineering Moderna Therapeutics
Tamara Ouspenskaia, PhD, is an Associate Director in Therapeutic Immunology and Protein Engineering at Moderna, where she leads efforts to develop and apply novel approaches to assess antigen immunogenicity and characterize antigen-specific T-cell responses. Her work spans translational research and therapeutic discovery.
Prior to joining Moderna, Tamara held scientific leadership roles at GSK and ProFound Therapeutics. She completed her postdoctoral training at the Broad Institute of MIT and Harvard in the laboratories of Aviv Regev and Catherine Wu, where her research focused on identifying cancer antigens arising from previously unannotated regions of the genome. She received her PhD from The Rockefeller University and holds MSc and BSc degrees from McGill University.
Seminars
- Examining how personalized cancer vaccines generate broad and durable tumor specific immune responses, drawing on findings from the intismeran clinical program
- Discussing how emerging translational insights are deepening our understanding of personalized cancer vaccine biology and informing the future development of this therapeutic approach
